研究疾病:
|
糖尿病肾脏疾病
|
研究疾病代码:
|
|
Target disease:
|
Diabetes and kidney disease
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
病例对照研究
Case-Control study
|
研究所处阶段:
Study phase:
|
I期临床试验
Phase I clinical trial
|
研究目的:
|
基于表型组学技术和中医肾病理论认识和临床实践,探索并验证DKD早中期(G2-G3a, A2- A3)主要中医证型-气虚血瘀证的基因多态性-蛋白质组-代谢组-肾功能联合精准诊断分子标志物谱。
|
Objectives of Study:
|
Based on phenotypic omics technology, theoretical understanding and clinical practice of TCM nephropathy, explore and verify the gene polymorphism proteome metabolome renal function combined accurate diagnosis molecular marker spectrum of qi deficiency and blood stasis syndrome, the main TCM syndrome type of DKD in the early and middle stages (g2-g3a, A2-A3).
|
药物成份或治疗方案详述:
|
DKD 早中期患者气虚血瘀证患者,随机分为中药肾浊方联合标准基础治疗组与单纯标准基础治疗对照组;单纯标准治疗组予宣传教育、饮食、生活方式及常规控制血糖、控制血压、调整脂代谢紊乱治疗;联合治疗组在基础治疗上加用肾浊方治疗(采用标准中药颗粒剂)
|
Description for medicine or protocol of treatment in detail:
|
Patients with Qi deficiency and blood stasis syndrome in the early and middle stage of DKD were randomly divided into the traditional Chinese medicine Shenzhuo formula combined with standard basic treatment group and the simple standard basic treatment control group; The simple standard treatment group was treated with propaganda and education, diet, lifestyle and routine blood sugar control, blood pressure control and lipid metabolism disorder adjustment; The combined treatment group was treated with Shenzhuo formula (standard Chinese medicine granules) in addition to the basic treatment
|
纳入标准:
|
健康人纳入标准
(1)符合健康人的诊断标准,中医体质判定为平和质;
(2)年龄:18-70 岁;
(3)血糖正常范围内;
(4)签署知情同意书者。
气虚血瘀证入选标准
(1)符合中医消渴肾病诊断标准且辨证分型为气虚血瘀证者,并符合西医糖尿病肾脏疾病诊断标准且肾功能分期为 G2-G3a 期,蛋白尿分期为 A2-A3 期。
(2)患者空腹血糖<8.0mol/L,餐后 2h 血糖≤11.0mmol/L,糖化血糖蛋白≤8.0%,老年患者可放宽至8.5%。
(3)患者血压未经控制或服用降压药物后,控制大于130/80mmHg 以下,舒张压不低于 70mmHg,老年患者舒张压不低于 60mmHg。
(4)年龄大于等于40岁且小于等于75岁患者。
(5)患者已知情,同意参加本研究者。
非气虚血瘀证入选标准
(1)符合中医消渴肾病诊断标准且辨证分型为湿热证者,并符合西医糖尿病肾脏疾病诊断标准且肾功能分期为 G2-G3a 期,蛋白尿分期为 A2-A3 期。
(2)患者空腹血糖<8.0mol/L,餐后 2h 血糖≤11.0mmol/L,糖化血糖蛋白≤8.0%,老年患者可放宽至8.5%。
(3)患者血压未经控制或服用降压药物后,控制大于130/80mmHg 以下,舒张压不低于 70mmHg,老年患者舒张压不低于 60mmHg。
(4)年龄大于等于40岁且小于等于75岁患者。
(5)患者已知情,同意参加本研究者。
|
Inclusion criteria
|
Inclusion criteria for healthy people
(1) It meets the diagnostic criteria of healthy people, and the constitution of traditional Chinese medicine is judged to be mild;
(2) Age: 18-70 years old;
(3) Blood glucose is within the normal range;
(4) Those who sign the informed consent form.
Inclusion criteria of qi deficiency and blood stasis syndrome
(1) Those who meet the diagnostic criteria of diabetes nephropathy in traditional Chinese medicine and the syndrome differentiation type is Qi deficiency and blood stasis syndrome, and those who meet the diagnostic criteria of diabetes kidney disease in western medicine and the renal function stage is g2-g3a, and the proteinuria stage is A2-A3.
(2) The fasting blood glucose of the patients is less than 8.0mmol/l, the blood glucose at 2h after meal is less than 11.0mmol/l, and the glycosylated glycemic protein is less than 8.0%, which can be relaxed to 8.5% in the elderly patients.
(3) The patient's blood pressure is not controlled or after taking antihypertensive drugs, the control is greater than 130 / 80mmHg, the diastolic blood pressure is not less than 70mmhg, and the diastolic blood pressure of elderly patients is not less than 60mmhg.
(4) Patients aged 40 years or older and 75 years or younger.
(5) The patient was informed and agreed to participate in this study.
Inclusion criteria of non Qi deficiency and blood stasis syndrome
(1) Those who meet the diagnostic criteria of diabetes nephropathy in traditional Chinese medicine and the syndrome differentiation type is damp heat syndrome, and those who meet the diagnostic criteria of diabetes kidney disease in western medicine and the renal function stage is g2-g3a, and the proteinuria stage is A2-A3.
(2) The fasting blood glucose of the patients is less than 8.0mmol/l, the blood glucose at 2h after meal is less than 11.0mmol/l, and the glycosylated glycemic protein is less than 8.0%, which can be relaxed to 8.5% in the elderly patients.
(3) The patient's blood pressure is not controlled or after taking antihypertensive drugs, the control is greater than 130 / 80mmHg, the diastolic blood pressure is not less than 70mmhg, and the diastolic blood pressure of elderly patients is not less than 60mmhg.
(4) Patients aged 40 years or older and 75 years or younger.
(5) The patient was informed and agreed to participate in this study.
|
排除标准:
|
健康人排除标准
(1)诊断中患有呼吸系统、消化系统、内分泌系统、心血管系统等疾病者;
(2)精神病患者;
(3)妊娠、准备妊娠或哺乳期妇女。
气虚血瘀证排除标准
(1)不符合气虚血瘀证患者诊断标准和纳入标准者;
(2)1 型糖尿病肾脏疾病患者;
(3)入选前出现糖尿病酮症、酮症酸中毒、高渗性昏迷、严重感染等急重症未纠正者;
(4)伴有严重心、肝、肾功能不全或恶性肿瘤者;
(5)过敏体质、妊娠期或哺乳期患者或对多种中药有过敏史者。
非气虚血瘀证排除标准
(1)不符合湿热证诊断标准和纳入标准者;
(2)1 型糖尿病肾脏疾病患者;
(3)入选前出现糖尿病酮症、酮症酸中毒、高渗性昏迷、严重感染等急重症未纠正者;
(4)伴有严重心、肝、肾功能不全或恶性肿瘤者;
(5)过敏体质、妊娠期或哺乳期患者或对多种中药有过敏史者。
|
Exclusion criteria:
|
Exclusion criteria for healthy people
(1) Patients with respiratory system, digestive system, endocrine system, cardiovascular system and other diseases during diagnosis;
(2) Mental patients;
(3) Women who are pregnant, preparing for pregnancy or breastfeeding.
Exclusion criteria of qi deficiency and blood stasis syndrome
(1) Those who do not meet the diagnostic criteria and inclusion criteria of patients with Qi deficiency and blood stasis syndrome;
(2) Patients with type 1 diabetes and kidney disease;
(3) Patients with acute and severe diseases such as diabetes ketosis, ketoacidosis, hyperosmolar coma, and severe infection were not corrected before enrollment;
(4) Patients with severe heart, liver and kidney dysfunction or malignant tumors;
(5) Allergic constitution, patients during pregnancy or lactation, or those who have a history of allergy to various traditional Chinese medicines.
Exclusion criteria of non Qi deficiency and blood stasis syndrome
(1) Those who do not meet the diagnostic criteria and inclusion criteria of damp heat syndrome;
(2) Patients with type 1 diabetes and kidney disease;
(3) Patients with acute and severe diseases such as diabetes ketosis, ketoacidosis, hyperosmolar coma, and severe infection were not corrected before enrollment;
(4) Patients with severe heart, liver and kidney dysfunction or malignant tumors;
(5) Allergic constitution, patients during pregnancy or lactation, or those who have a history of allergy to various traditional Chinese medicines.
|
研究实施时间:
Study execute time:
|
从From
2022-09-05
至To
2023-10-31
|
征募观察对象时间:
Recruiting time:
|
从From
2022-09-05
至To
2023-10-31
|